NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS

被引:411
作者
TIMMERMANS, PBMWM
WONG, PC
CHIU, AT
HERBLIN, WF
机构
[1] Research Associates at, Pont Merck Pharmaceutical Co., Wilmington
关键词
D O I
10.1016/0165-6147(91)90498-H
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Substantial progress has been made recently in the development of nonpeptide angiotensin II receptor antagonists, a goal that has long remained an unmet challenge. Pieter Timmermans and colleagues review the pharmacology and the course of events that led to the identification of the lead compound and clinical candidate DuP753. Nonpeptide angiotensin II receptor antagonists represent novel therapeutic agents and are the preferred probes for exploring the (patho)physiological role(s) of angiotensin II. In addition, these compounds have provided evidence for the existence of different binding sites/receptors for angiotensin II.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 35 条
[1]  
BLANKLEY CJ, 1988, Patent No. 245637
[2]  
BRUNNER HR, 1974, CIRC RES, V34, pI35
[3]  
CHANG RSL, 1990, MOL PHARMACOL, V37, P347
[4]  
Chiu A T, 1990, Receptor, V1, P33
[5]  
CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
[6]   IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES [J].
CHIU, AT ;
HERBLIN, WF ;
MCCALL, DE ;
ARDECKY, RJ ;
CARINI, DJ ;
DUNCIA, JV ;
PEASE, LJ ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :196-203
[7]   DISCRIMINATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES BY DITHIOTHREITOL [J].
CHIU, AT ;
MCCALL, DE ;
NGUYEN, TT ;
CARINI, DJ ;
DUNCIA, JV ;
HERBLIN, WF ;
UYEDA, RT ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 170 (1-2) :117-118
[8]   NON-PEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .2. PHARMACOLOGY OF S-8308 [J].
CHIU, AT ;
CARINI, DJ ;
JOHNSON, AL ;
MCCALL, DE ;
PRICE, WA ;
THOOLEN, MJMC ;
WONG, PC ;
TABER, RI ;
TIMMERMANS, PBMWM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 157 (01) :13-21
[9]  
CHRISTEN Y, 1990, J HYPERTENS, V8, pS119
[10]  
CORVOL P, 1990, HYPERTENSION, V16, P1